Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
ENRYLAZE Inj Lös 10 mg/0.5ml 3 Durchstf 0.5 ml
Drug
Enrylaze, Injektionslösung
Akute lymphatische Leukämie (ALL), lymphoblastisches Lymphom (LBL)
07.16.1. – cytostatics
HAM – Human medicine
LSIN – solution for injection/infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
4/18/2024
4/17/2029
Dosage strength
Enrylaze 10 mg/vial, Injektionslösung
Akute lymphatische Leukämie (ALL), lymphoblastisches Lymphom (LBL)
01
Z – approved
Package
7680690730017
No information made available
A/R – Authorised / referenced
3 vial(s)
001
Z – approved
Declaration
Component
10 mg crisantaspasum
trehalosum dihydricum
natrii chloridum
dinatrii phosphas
natrii dihydrogenophosphas monohydricus
polysorbatum 80
natrii hydroxidum
aqua ad iniectabile
ca. 1 mg natrium
natrii chloridum
dinatrii phosphas
natrii dihydrogenophosphas monohydricus
polysorbatum 80
natrii hydroxidum
aqua ad iniectabile
ca. 1 mg natrium
Authorisation holder
7601001383715
Jazz Pharmaceuticals
Grafenauweg 8
6300 Zug (ZG)
Grafenauweg 8
6300 Zug (ZG)
Date of revision of the text
10/30/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.